KLTO has 36-month beta value of 0.14.
The public float for KLTO is 26.77M, and currently, short sellers hold a 8.64% ratio of that float. The average trading volume of KLTO on June 05, 2025 was 10.79M shares.
KLTO) stock’s latest price update
The stock of Klotho Neurosciences Inc (NASDAQ: KLTO) has increased by 6.36 when compared to last closing price of 0.18.Despite this, the company has seen a gain of 0.47% in its stock price over the last five trading days. globenewswire.com reported 2025-01-08 that NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) — Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s disease, announces that it will present at Biotech Showcase 2025, an event expected to include over 3,200 healthcare professionals with more than 1,200 investors. The event will be held at the Hilton Hotel in Union Square, San Francisco during the J.P.
KLTO’s Market Performance
Klotho Neurosciences Inc (KLTO) has seen a 0.47% rise in stock performance for the week, with a 6.89% gain in the past month and a -33.95% plunge in the past quarter. The volatility ratio for the week is 3.96%, and the volatility levels for the past 30 days are at 22.52% for KLTO. The simple moving average for the past 20 days is -0.39% for KLTO’s stock, with a -55.55% simple moving average for the past 200 days.
KLTO Trading at 3.36% from the 50-Day Moving Average
After a stumble in the market that brought KLTO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.38% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at KLTO starting from CHARDAN CAPITAL MARKETS LLC, who sale 180,000 shares at the price of $2.05 back on Jul 02 ’24. After this action, CHARDAN CAPITAL MARKETS LLC now owns 1,284,364 shares of Klotho Neurosciences Inc, valued at $368,442 using the latest closing price.
CHARDAN CAPITAL MARKETS LLC, the 10% Owner of Klotho Neurosciences Inc, sale 115,136 shares at $2.06 during a trade that took place back on Jul 01 ’24, which means that CHARDAN CAPITAL MARKETS LLC is holding 1,464,364 shares at $237,618 based on the most recent closing price.
Stock Fundamentals for KLTO
The total capital return value is set at -4.23. Equity return is now at value -131.50, with -68.33 for asset returns.
Based on Klotho Neurosciences Inc (KLTO), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -9.72. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -14.35.
Currently, EBITDA for the company is -5.79 million with net debt to EBITDA at -0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.29.
Conclusion
To put it simply, Klotho Neurosciences Inc (KLTO) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
